Tirumalai Rangasamy
Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
NF-E2-Related Factor 2 | 9 | 2004 | 15 |
Why?
|
Lung | 10 | 2004 | 232 |
Why?
|
Emphysema | 2 | 2004 | 5 |
Why?
|
Smoking | 3 | 2004 | 153 |
Why?
|
Oxidative Stress | 7 | 2005 | 119 |
Why?
|
Up-Regulation | 3 | 2004 | 183 |
Why?
|
Respiratory Hypersensitivity | 1 | 2011 | 7 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2011 | 15 |
Why?
|
Trans-Activators | 2 | 2004 | 113 |
Why?
|
Dendritic Cells | 2 | 2008 | 60 |
Why?
|
Ambrosia | 1 | 2009 | 3 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 204 |
Why?
|
Plant Extracts | 1 | 2009 | 22 |
Why?
|
Transcription Factors | 2 | 2010 | 201 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 138 |
Why?
|
Asthma | 2 | 2005 | 97 |
Why?
|
Apoptosis | 3 | 2004 | 265 |
Why?
|
Mice | 14 | 2004 | 623 |
Why?
|
Deoxyguanosine | 1 | 2004 | 7 |
Why?
|
Smoke | 3 | 2006 | 20 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 131 |
Why?
|
Mice, Inbred ICR | 4 | 2004 | 34 |
Why?
|
Mice, Knockout | 6 | 2005 | 265 |
Why?
|
Animals | 14 | 2004 | 1031 |
Why?
|
Pulmonary Emphysema | 2 | 2008 | 24 |
Why?
|
Antioxidants | 4 | 2004 | 84 |
Why?
|
Tobacco | 2 | 2006 | 24 |
Why?
|
Lymphocyte Activation | 2 | 2008 | 137 |
Why?
|
Benzo(a)pyrene | 2 | 2003 | 7 |
Why?
|
Th2 Cells | 2 | 2005 | 36 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2004 | 135 |
Why?
|
Oxidation-Reduction | 2 | 2004 | 124 |
Why?
|
Gene Expression Regulation | 3 | 2005 | 277 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2006 | 73 |
Why?
|
Bone Marrow Cells | 2 | 2008 | 92 |
Why?
|
Allergens | 1 | 2011 | 28 |
Why?
|
Homeostasis | 2 | 2007 | 99 |
Why?
|
Pulmonary Alveoli | 3 | 2004 | 80 |
Why?
|
Mice, Inbred A | 1 | 2009 | 15 |
Why?
|
Elasticity | 1 | 2009 | 30 |
Why?
|
Chalcones | 1 | 2008 | 1 |
Why?
|
Oleanolic Acid | 1 | 2008 | 13 |
Why?
|
Nucleic Acid Hybridization | 1 | 2009 | 94 |
Why?
|
Anticarcinogenic Agents | 1 | 2008 | 8 |
Why?
|
DNA Adducts | 1 | 2008 | 12 |
Why?
|
Trachea | 1 | 2009 | 50 |
Why?
|
Oxidants | 1 | 2009 | 47 |
Why?
|
Particulate Matter | 1 | 2008 | 22 |
Why?
|
Anoxia | 1 | 2009 | 85 |
Why?
|
Heart Diseases | 1 | 2008 | 92 |
Why?
|
Protein-Serine-Threonine Kinases | 1 | 2010 | 105 |
Why?
|
Muscle Contraction | 1 | 2009 | 77 |
Why?
|
Extracellular Matrix | 1 | 2009 | 79 |
Why?
|
Flow Cytometry | 1 | 2009 | 216 |
Why?
|
Interferon-gamma | 1 | 2009 | 133 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2009 | 35 |
Why?
|
Inhalation Exposure | 1 | 2007 | 22 |
Why?
|
Chronic Disease | 1 | 2009 | 267 |
Why?
|
Transcription, Genetic | 3 | 2004 | 253 |
Why?
|
Glutathione Peroxidase | 1 | 2006 | 24 |
Why?
|
Mice, Transgenic | 2 | 2004 | 209 |
Why?
|
Cells, Cultured | 2 | 2008 | 447 |
Why?
|
Chemokine CCL11 | 1 | 2005 | 10 |
Why?
|
Ovalbumin | 1 | 2005 | 32 |
Why?
|
Cytokines | 1 | 2009 | 207 |
Why?
|
NF-kappa B | 2 | 2005 | 114 |
Why?
|
Immunity, Innate | 1 | 2006 | 60 |
Why?
|
Chemokines, CC | 1 | 2005 | 15 |
Why?
|
Sepsis | 1 | 2006 | 73 |
Why?
|
Acetylcysteine | 1 | 2005 | 42 |
Why?
|
T-Lymphocytes | 1 | 2009 | 182 |
Why?
|
Male | 6 | 2005 | 1553 |
Why?
|
Bronchoalveolar Lavage | 1 | 2004 | 24 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 65 |
Why?
|
DNA, Complementary | 1 | 2005 | 139 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2005 | 68 |
Why?
|
Base Sequence | 2 | 2005 | 371 |
Why?
|
Acrolein | 1 | 2003 | 7 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 137 |
Why?
|
DNA, Neoplasm | 1 | 2003 | 75 |
Why?
|
Cell Differentiation | 1 | 2008 | 262 |
Why?
|
Epithelial Cells | 1 | 2004 | 135 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2003 | 82 |
Why?
|
Phenotype | 1 | 2004 | 303 |
Why?
|
Time Factors | 2 | 2004 | 896 |
Why?
|
Immunohistochemistry | 1 | 2004 | 355 |
Why?
|
Inflammation | 1 | 2004 | 208 |
Why?
|
Humans | 6 | 2003 | 1856 |
Why?
|
Lung Neoplasms | 1 | 2003 | 159 |
Why?
|
Adenocarcinoma | 1 | 2003 | 167 |
Why?
|
Luciferases | 2 | 2003 | 70 |
Why?
|
Mice, Inbred C57BL | 2 | 2007 | 318 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 21 |
Why?
|
RNA, Messenger | 2 | 2006 | 394 |
Why?
|
Jurkat Cells | 1 | 2009 | 26 |
Why?
|
Antigens, CD3 | 1 | 2009 | 37 |
Why?
|
Baltimore | 1 | 2008 | 14 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 77 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 22 |
Why?
|
Imidazoles | 1 | 2008 | 47 |
Why?
|
Coculture Techniques | 1 | 2008 | 59 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2007 | 5 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 55 |
Why?
|
Enzyme Activation | 1 | 2010 | 177 |
Why?
|
Stress, Mechanical | 1 | 2009 | 93 |
Why?
|
Blotting, Northern | 1 | 2008 | 151 |
Why?
|
RNA, Double-Stranded | 1 | 2007 | 11 |
Why?
|
Interferons | 1 | 2007 | 39 |
Why?
|
Genes, Reporter | 1 | 2008 | 111 |
Why?
|
GTP Phosphohydrolases | 1 | 2007 | 21 |
Why?
|
Signal Transduction | 2 | 2006 | 313 |
Why?
|
Immunity | 1 | 2007 | 46 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 25 |
Why?
|
Organ Size | 1 | 2007 | 118 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 176 |
Why?
|
Macrophages, Alveolar | 1 | 2007 | 44 |
Why?
|
Cell Death | 1 | 2007 | 94 |
Why?
|
Cell Count | 1 | 2007 | 163 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 54 |
Why?
|
Cecum | 1 | 2006 | 11 |
Why?
|
Nitric Oxide | 1 | 2008 | 85 |
Why?
|
Down-Regulation | 1 | 2007 | 150 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2006 | 88 |
Why?
|
Response Elements | 1 | 2006 | 40 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2009 | 113 |
Why?
|
Oxygen | 1 | 2009 | 179 |
Why?
|
Cell Adhesion Molecules | 1 | 2006 | 48 |
Why?
|
Animals, Newborn | 1 | 2007 | 175 |
Why?
|
RNA Interference | 1 | 2006 | 75 |
Why?
|
RNA, Viral | 1 | 2007 | 91 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 116 |
Why?
|
Chemokines | 1 | 2006 | 48 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 431 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 98 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 104 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 115 |
Why?
|
Pneumonia | 1 | 2006 | 85 |
Why?
|
Buthionine Sulfoximine | 1 | 2003 | 11 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2003 | 29 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2003 | 45 |
Why?
|
Precipitin Tests | 1 | 2003 | 81 |
Why?
|
Protein Binding | 1 | 2006 | 256 |
Why?
|
Transfection | 1 | 2006 | 237 |
Why?
|
Nuclear Proteins | 1 | 2006 | 139 |
Why?
|
Cell Line | 1 | 2006 | 375 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2006 | 210 |
Why?
|
Glutathione | 1 | 2003 | 65 |
Why?
|
Blotting, Western | 1 | 2003 | 275 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 404 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 233 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 188 |
Why?
|
Rats | 1 | 2006 | 530 |
Why?
|
Female | 1 | 2009 | 1643 |
Why?
|
